Rabavert rabies vacc w-diluents
Ended Awarded
- Contract number
- SPE2DB25FX2EN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,506
Award facts
- Contract value 100% obligated
- $13,506.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,506.00 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 9, 2025, for the supply of Rabavert rabies vaccine with diluents. The contract, which has no set-aside designation, is scheduled for completion by September 10, 2025, with performance taking place at the contractor's facility in Park Ridge, Illinois. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler that has been registered in the System for Award Management since 2001 and specializes in providing medical supplies and medications to federal agencies, particularly the Department of Defense healthcare systems.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and effective through November 2026. The IDC, established under the SPE2DB program, enables the agency to procure a comprehensive range of pharmaceutical products, including prescription medications, biologics, vaccines, and medical consumables to support military health facilities nationwide. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in federal procurement while maintaining a robust portfolio of vaccine and pharmaceutical product deliveries to the Department of Defense.
Quick answers
Who was awarded contract SPE2DB25FX2EN?
SPE2DB25FX2EN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 9, 2025.
How much is contract SPE2DB25FX2EN worth?
The government has obligated $13,506 on SPE2DB25FX2EN.
Is contract SPE2DB25FX2EN an order under another contract?
Yes. SPE2DB25FX2EN is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB25FX2EN competed?
The extent of competition for SPE2DB25FX2EN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award